Form D · Other Health Care

Vermedx Inc.

Burlington, VT · CIK 0001463210

Offering snapshot reported May 26, 2015 · SEC filing

Reported sold
$251K
Offering amount: $500K
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 20, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 26, 2015Initial$250,642No comparison11SEC filing
Feb 11, 2014Initial$258,989No comparison11SEC filing
Jun 19, 2012Initial$952,031No comparison10SEC filing
Sep 28, 2011Initial$350,000No comparison5SEC filing
Oct 19, 2010Initial$800,000No comparison8SEC filing
Mar 4, 2010Initial$350,000No comparison3SEC filing
May 5, 2009Initial$500,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-240521

Source: Form D, filed May 26, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Lee Bouyea Director
Richard Elmore Director
Michael Gagnon Executive
Reginald Gignoux Director
Stanley Goldstein Director, Executive
Benjamin Littenberg Director, Executive
Michael Mac Caskey Executive
Charles Mac Lean Executive
David Potter Director
Henry Tufo Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
239 S. Union Street
Burlington, VT, 05401